“Lose weight and revitalize the country”? Goldman Sachs: Diet pills may increase US GDP by 1% in the next few years
As the domestic Spring Festival program “Hot and Hot” once again attracted people's attention to weight loss tracks, Goldman Sachs recently once again emphasized the prospects of diet pills and their wider impact on the macroeconomy in the US stock market.
As diet pills continue to be “hot and hot,” Goldman Sachs boldly predicts that it will increase US GDP by 1% in the next few years!
Analyst Jan Hatzius and his team believe that obese people are less likely to work and work less efficiently. So, assuming that America's obesity rate is over 40%, their impact on the country's total output is more than 1%.
Obesity Drugs to Expand U.S. GDP by 1% in the Coming Years: Goldman Sachs
Biotech's First IPO of 2024 Popped 96%. What It Means.
Biotech stocks have fallen about 1% so far this year.
Here's Why Structure Therapeutics (GPCR) Fell in Q4
The “rising star of diet pills” made a big splash: it is expected that within 50 years, diet pills will become “standard medicine”
The CEO of Zealand Pharma said the company's new drug could surpass Wegovy as well as Zepbound; the biotech company is awaiting data on weight loss drugs targeting the hormone insulin.